Abstract:The progesterone receptor ( PR) plays roles in normal mammary development and breast cancer formation, where it may exert both stimulatory and inhibitory actions. Previously, the breast cancer susceptibility gene product BRCA1 was found to interact with and inhibit the transcriptional activity of estrogen receptor-alpha. In this study, we found that exogenous wild-type BRCA1 inhibited the activity of the PR in transient transfection assays utilizing a mouse mammary tumor virus-Luc reporter. Wildtype BRCA1 inhibited the activity of endogenous PR in human breast cancer cells ( T47D and MCF-7) and inhibited the activity of exogenous PR-A, PR-B, and [ PR-A plus PR-B] isoforms. On the other hand, knockdown of endogenous BRCA1 using small interfering RNA enhanced the progesterone-stimulated activity of the PR by about 4-fold. We documented an in vivo association of the endogenous BRCA1 with PR isoforms A and B and a direct in vitro interaction between BRCA1 and PR, which was partially mapped. Whereas down-regulation of the coactivator p300 contributes to the BRCA1-mediated repression of estrogen receptor-alpha, this mechanism does not contribute to inhibition of PR activity, because exogenous p300 did not rescue the BRCA1 repression of PR activity. The BRCA1-PR interaction has functional consequences. Thus, we showed that BRCA1 inhibits the expression of various endogenous progesterone-responsive genes and inhibits progesterone-stimulated proliferation of T47D cells. Finally, exogenous progesterone caused an exaggerated proliferative response in the mammary glands of mice harboring a mammary-targeted conditional deletion of the full-length isoform of Brca1. These findings suggest that BRCA1 regulates the activity of progesterone, a major hormone of pregnancy that may also participate in mammary carcinogenesis.

Regulation of progesterone receptor signaling by BRCA1 in mammary cancer.

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

BRCA1 in hormone-responsive cancers.

BRCA1 in Hormonal Carcinogenesis: Basic and Clinical Research

Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.

BRCA1-associated Mammary Tumorigenesis is Dependent on Estrogen Rather Than Progesterone Signaling

BRCA1 Regulates Human Mammary Stem/progenitor Cell Fate

Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.

BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells

Growth Factor Signaling Pathways Modulate Brca1 Repression of Estrogen Receptor-Alpha Activity

Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations

A role of estrogen|[sol]|ER|[alpha]| signaling in BRCA1-associated tissue-specific tumor formation

A Role of Estrogen/erα Signaling in BRCA1-associated Tissue-Specific Tumor Formation

BRCA1 As a Potential Human Prostate Tumor Suppressor: Modulation of Proliferation, Damage Responses and Expression of Cell Regulatory Proteins

TRPS1 Regulates the Opposite Effect of Progesterone Via RANKL in Endometrial Carcinoma and Breast Carcinoma

Mouse Models for BRCA1-associated Breast Cancer

BRCA mutations in the manifestation and treatment of ovarian cancer.

BRCA1 regulation of transcription

Brca1 Gene In Breast Cancer

Inhibition Of Estrogen Signaling Reduces The Incidence Of Brca1-Associated Mammary Tumor Formation

BRCA1 regulates gene expression for orderly mitotic progression.